Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
4.790
-0.210 (-4.20%)
Feb 21, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Stock Forecast
SLN's stock price has decreased by -80.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 46.25, with a low estimate of 6.00 and a high estimate of 75. The average target predicts an increase of 865.55% from the current stock price of 4.79.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Silence Therapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Sell Initiates $6 | Strong Sell | Initiates | $6 | +25.26% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,465.76% | Feb 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,465.76% | Jan 29, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 | Strong Buy | Maintains | $55 | +1,048.23% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,465.76% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
15.78M
from 25.38M
Decreased by -37.82%
Revenue Next Year
32.34M
from 15.78M
Increased by 104.98%
EPS This Year
n/a
from -1.17
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 27.7M | 74.5M |
| Avg | 15.8M | 32.3M |
| Low | 1.0M | 10.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 9.3% | 372.1% |
| Avg | -37.8% | 105.0% |
| Low | -96.0% | -34.9% |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.